Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01713569 · ClinicalTrials.gov registry record · NA
Feasibility Study: Histological Characterization After Treatment With the Ulthera® System
A NA study, sponsored by Ulthera.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01713569 is a NA study that was terminated before completion, run by Ulthera. The registered enrollment target is 2 participants.
The verdict
NCT01713569, a NA study, was terminated before completion, sponsored by Ulthera.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Up to 6 subjects will be enrolled. Subjects who have already chosen to have a surgical facelift procedure will be enrolled. Subjects will receive selective Ulthera® ultrasound exposures in the pre-auricular regions. Subject will return for a follow-up visit up to 48 hours post-treatment, on the day of their rhytidectomy. Study images will be obtained pretreatment, immediately post-treatment, and at the follow-up visit.
Interventions
- DEVICE Ulthera Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01713569
The ClinicalTrials.gov registry entry for NCT01713569 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera Treatment is the first listed.
NCT01713569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01713569 about?
NCT01713569 is a clinical study titled "Feasibility Study: Histological Characterization After Treatment With the Ulthera® System". Up to 6 subjects will be enrolled. Subjects who have already chosen to have a surgical facelift procedure will be enrolled. Subjects will receive selective Ulthera® ultrasound exposures in the pre-auricular regions. Subject will return for a follow-up visit up to 48 hours post-treatment, on the day ...
What is the current status of trial NCT01713569?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2012-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01713569?
The interventions under investigation include: Ulthera Treatment (DEVICE).
Who is sponsoring clinical trial NCT01713569?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.